Value of Ondansetron Medication vs Inhaled Isopropyl Therapy in the Emergency Department (VOMIITED)
NCT03125811 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 121
Last updated 2023-08-29
Summary
This study will compare two different ways to relieve nausea and vomiting in the Emergency Department. The usual treatment for nausea/vomiting is a drug called Zofran, but new studies have suggested that smelling alcohol pads can also help to relieve nausea and vomiting.
Conditions
Interventions
- OTHER
-
Inhaled Isopropyl Alcohol (IPA)
Three doses within 60 minutes. Doses will occur at 0 minutes, 30 minutes, and 60 minutes. Each dose consists of 3 inhalations of one IPA prep pad. A new prep pad is used at each dose.
- DRUG
-
Oral Dissolvable Tablet Zofran (ondansetron)
Single dose 4 mg tablet at 0 minutes.
Sponsors & Collaborators
-
Texas Tech University Health Sciences Center, El Paso
lead OTHER
Principal Investigators
-
Scott Crawford, MD · Texas Tech Universtiy Health Sciences Center El Paso
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-07-17
- Primary Completion
- 2023-03-01
- Completion
- 2023-03-01
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Inhaled Isopropyl Alcohol for Treatment of Nausea
NCT05418244 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Ondansetron Versus Dexamethasone/Ondansetron to Treat Acute Nausea in the Emergency Department
NCT02985840 ·Status: TERMINATED ·Phase: PHASE4
-
Ondansetron vs Prochlorperazine for Nausea and Vomiting in the Emergency Department
NCT00590317 ·Status: COMPLETED ·Phase: PHASE2
-
Inhaled IAV vs Inhaled Eucalyptus for the Treatment of Nausea With Acute Migraine
NCT05175521 ·Status: COMPLETED ·Phase: NA
-
Comparison of Ondansetron, Metoclopramide and Promethazine for the Treatment of Nausea and Vomiting in the Adult ED
NCT00655642 ·Status: TERMINATED ·Phase: NA
-
A RCT of Ondansetron and Promethazine in the Treatment of Nausea and Vomiting in the Emergency Department
NCT00429832 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Ondansetron Dose and Timing on Post-operative Nausea and Vomiting
NCT03297021 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of the Administration of Ondansetron Versus Habitual Clinical Practice for the Treatment of Vomiting in Children With Mild and Moderate Dehydration: Randomized Clinical Trial
NCT04318847 ·Status: UNKNOWN ·Phase: PHASE4
-
Ondansetron Reduce Vomiting Associated With Ketamine PSA
NCT00387556 ·Status: COMPLETED ·Phase: NA
-
Ondansetron Versus Metoclopramide in Treatment of Vomiting in Gastroenteritis
NCT01165866 ·Status: COMPLETED ·Phase: PHASE4
-
Oral Disintegrating Ondansetron Tablet to Reduce Vomiting From Gastroenteritis in a Pediatric Emergency Department
NCT00120744 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate Rate of Nausea in Healthy Premenopausal Female Subjects Treated With Single Dose of Bremelanotide Alone or With Zofran
NCT03973047 ·Status: COMPLETED ·Phase: PHASE1
-
Antiemetic Efficacy of Ondansetron Versus Metoclopramide
NCT02619201 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy Study of IV Fluids Only vs Ondansetron to Treat Dehydration
NCT00691275 ·Status: WITHDRAWN ·Phase: NA
-
Dronabinol Versus Standard Ondansetron Antiemetic Therapy in Preventing Delayed-Onset Chemotherapy-Induced Nausea and Vomiting
NCT00642512 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of Aprepitant in Addition to Ondansetron in the Prevention of Nausea and Vomiting Caused by Upper Abdominal Radiotherapy
NCT00970905 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Antiemetic Drugs in Preventing Delayed Nausea After Chemotherapy in Patients With Cancer
NCT00020657 ·Status: COMPLETED ·Phase: PHASE3
-
Phase 1 Safety, Tolerability and PK Study of Ondansetron and Hylenex Recombinant in Healthy Volunteers
NCT01572012 ·Status: COMPLETED ·Phase: PHASE1
-
Immediate Nausea and Vomiting After the Administration of Non-ionic Contrast Media
NCT03019341 ·Status: COMPLETED
-
Ondansetron Oral Versus Orally Disintegrating Tablets (ODT)
NCT02174874 ·Status: COMPLETED
-
the Efficacy and Safety of Ondansetron Oral Soluble Pellicles
NCT06282211 ·Status: RECRUITING ·Phase: PHASE3
-
Intranasal Lidocaine for Prevention of Postoperative Nausea and Vomiting.
NCT04810494 ·Status: WITHDRAWN ·Phase: PHASE4
-
Safety and Efficacy of Palonosetron IV to Prevent Postoperative Nausea and Vomiting in Pediatric Patients
NCT01395901 ·Status: COMPLETED ·Phase: PHASE3
-
To Demonstrate the Relative Bioavailability Study of Ondansetron HCl 24 mg Tablets Under Non-Fasting Conditions
NCT00947128 ·Status: COMPLETED ·Phase: PHASE1
-
Does First Oral Intake After Emergence Predict the Incidence of Post-operative Vomiting in Children?
NCT01725399 ·Status: COMPLETED ·Phase: NA